aminoglutethimide has been researched along with Recrudescence in 5 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of our study was to determine the clinical relevance of cyclin D1 expression in hormone receptor-positive breast cancer patients who were treated with tamoxifen-based therapy." | 9.13 | Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. ( Dietze, O; Filipits, M; Gnant, MF; Greil, R; Grill, R; Huynh, A; Jakesz, R; Kwasny, W; Lax, S; Lehnert, M; Rudas, M; Schippinger, W; Singer, C; Stierer, M; Stiglbauer, W, 2008) |
| "The objective of our study was to determine the clinical relevance of cyclin D1 expression in hormone receptor-positive breast cancer patients who were treated with tamoxifen-based therapy." | 5.13 | Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. ( Dietze, O; Filipits, M; Gnant, MF; Greil, R; Grill, R; Huynh, A; Jakesz, R; Kwasny, W; Lax, S; Lehnert, M; Rudas, M; Schippinger, W; Singer, C; Stierer, M; Stiglbauer, W, 2008) |
| "We report three cases of long-term treatment of ectopic ACTH syndrome due to metastatic bronchial carcinoid, islet cell carcinoma, and malignant thymoma tumors." | 2.40 | Long-term medical treatment of ectopic ACTH syndrome. ( Comi, RJ; Gorden, P, 1998) |
| "Almost all patients with prostatic cancer will eventually escape the control of the first-line endocrine therapy and relapse." | 2.38 | Management of relapsing disease in prostate cancer. ( Denis, L; Mahler, C, 1992) |
| "In 74% of the acute myeloid leukemia patients, the truncated inhibitor was detected." | 1.29 | Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. ( Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudas, M | 1 |
| Lehnert, M | 1 |
| Huynh, A | 1 |
| Jakesz, R | 1 |
| Singer, C | 1 |
| Lax, S | 1 |
| Schippinger, W | 1 |
| Dietze, O | 1 |
| Greil, R | 1 |
| Stiglbauer, W | 1 |
| Kwasny, W | 1 |
| Grill, R | 1 |
| Stierer, M | 1 |
| Gnant, MF | 1 |
| Filipits, M | 1 |
| Dengler, R | 1 |
| Plewan, A | 1 |
| Münstermann, U | 1 |
| Busch, R | 1 |
| Eger, G | 1 |
| Emmerich, B | 1 |
| Comi, RJ | 1 |
| Gorden, P | 1 |
| Dowdell, KC | 1 |
| Gienapp, IE | 1 |
| Stuckman, S | 1 |
| Wardrop, RM | 1 |
| Whitacre, CC | 1 |
| Mahler, C | 1 |
| Denis, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase III Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal, Hormone Receptor-positive Patients[NCT00309491] | Phase 3 | 2,021 participants (Actual) | Interventional | 1990-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for aminoglutethimide and Recrudescence
| Article | Year |
|---|---|
Long-term medical treatment of ectopic ACTH syndrome.
Topics: ACTH Syndrome, Ectopic; Adolescent; Adrenocortical Hyperfunction; Aminoglutethimide; Antineoplastic | 1998 |
Management of relapsing disease in prostate cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Estrogens | 1992 |
1 trial available for aminoglutethimide and Recrudescence
| Article | Year |
|---|---|
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; B | 2008 |
2 other studies available for aminoglutethimide and Recrudescence
| Article | Year |
|---|---|
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; | 1995 |
Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis.
Topics: Adrenergic beta-Antagonists; Aminoglutethimide; Animals; Anti-Inflammatory Agents; Corticosterone; E | 1999 |